AR080287A1 - Intermediario sintetico de un compuesto de oxazol y metodo para producir el mismo - Google Patents
Intermediario sintetico de un compuesto de oxazol y metodo para producir el mismoInfo
- Publication number
- AR080287A1 AR080287A1 ARP110100285A ARP110100285A AR080287A1 AR 080287 A1 AR080287 A1 AR 080287A1 AR P110100285 A ARP110100285 A AR P110100285A AR P110100285 A ARP110100285 A AR P110100285A AR 080287 A1 AR080287 A1 AR 080287A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- formula
- compound represented
- phenyl
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un objeto de la presente es proveer un método para producir un compuesto de oxazol con un alto rendimiento. El objeto se puede lograr por medio de un compuesto representado por la Formula (1): en donde: R1 es un átomo de hidrogeno o un grupo alquilo inferior; R2 es un grupo 1-piperidilo substituido en la posicion 4 con un substituyente seleccionado entre: (A1a) un grupo fenoxi substituido en la parte fenilo con uno o más grupos alcoxi inferior substituidos con halogeno. (A1b) un grupo alquilo inferior substituido con fenoxi, substituido en la parte fenilo con uno o más grupos alquilo inferior substituidos con halogeno, (A1c) un grupo alquilo inferior alcoxi inferior substituido con fenilo, substituido en la parte fenilo con halogeno, (A1d) un grupo alquilo inferior substituido con fenilo, substituido en la parte fenilo con uno o más grupos alcoxi inferior substituidos con halogeno, (A1e) un grupo amino substituido con un grupo fenilo, substituido con uno o más grupos alcoxi inferior substituidos con halogeno, y un grupo alquilo inferior, y (A1f) un grupo alcoxi inferior substituido con fenilo, substituido en la parte fenilo con uno o más grupos alcoxi inferior substituidos con halogeno; n es un entero de 1 a 6; y X3 es un grupo sulfoniloxi orgánico. Reivindicacion 5: Un método para producir un compuesto representado por la Formula (2): en donde R1, R2 y n son los mismos que los que se definieron en la reivindicacion 1, método caracterizado porque comprende someter el compuesto de acuerdo con la reivindicacion 1 a una reaccion de epoxidacion. Reivindicacion 6: Un método para producir un compuesto representado por la Formula (3): en donde R1, R2 y n son los mismos que los definidos en la reivindicacion 1, método caracterizado porque comprende los pasos (a) a (c): (a) someter el compuesto de acuerdo con la reivindicacion 1 a una reaccion de epoxidacion para preparar un compuesto representado por la Formula (2): en donde R1, R2 y n son los mismos que los definidos en la reivindicacion 1; (b) hacer reaccionar un compuesto representado por la Formula (2) con un compuesto representado por la Formula (4) en donde X2 es un átomo de halogeno, para preparar un compuesto representado por la Formula (5): en donde R1, R2, X2 y n son los mismos que los definidos más arriba; y (c) someter el compuesto representado por la Formula (5) a una reaccion de cierre del anillo para preparar el compuesto representado por la Formula (1).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010019289 | 2010-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080287A1 true AR080287A1 (es) | 2012-03-28 |
Family
ID=43759747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110100285A AR080287A1 (es) | 2010-01-29 | 2011-01-28 | Intermediario sintetico de un compuesto de oxazol y metodo para producir el mismo |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8598358B2 (es) |
| EP (1) | EP2528896B1 (es) |
| JP (1) | JP5818802B2 (es) |
| KR (1) | KR101839160B1 (es) |
| CN (1) | CN102725269B (es) |
| AR (1) | AR080287A1 (es) |
| AU (1) | AU2011211311A1 (es) |
| BR (1) | BR112012018069A2 (es) |
| CA (1) | CA2787246A1 (es) |
| CY (1) | CY1115654T1 (es) |
| DK (1) | DK2528896T3 (es) |
| EA (1) | EA201290681A1 (es) |
| EG (1) | EG26595A (es) |
| ES (1) | ES2509946T3 (es) |
| HK (1) | HK1174031A1 (es) |
| HR (1) | HRP20141087T1 (es) |
| IL (1) | IL220754A (es) |
| MX (1) | MX2012008501A (es) |
| MY (1) | MY156360A (es) |
| NZ (1) | NZ601239A (es) |
| PL (1) | PL2528896T3 (es) |
| PT (1) | PT2528896E (es) |
| SG (1) | SG181990A1 (es) |
| SI (1) | SI2528896T1 (es) |
| TW (1) | TW201200523A (es) |
| UA (1) | UA108092C2 (es) |
| WO (1) | WO2011093529A1 (es) |
| ZA (1) | ZA201204802B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016119706A1 (zh) | 2015-01-29 | 2016-08-04 | 南京明德新药研发股份有限公司 | 抗肺结核病的硝基咪唑衍生物 |
| WO2016158737A1 (ja) * | 2015-03-27 | 2016-10-06 | 大塚製薬株式会社 | １－（４－ヒドロキシフェニル）－４－（４－トリフルオロメトキシフェノキシ）ピペリジン又はその塩の製造方法 |
| WO2020202205A1 (en) * | 2019-04-01 | 2020-10-08 | Council Of Scientific And Industrial Research | Process for the preparation of derivatives of 1,1-dialkylethane-1,2-diols as useful intermediates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2871063B2 (ja) | 1990-10-26 | 1999-03-17 | 日本たばこ産業株式会社 | （ｒ，ｚ）―５―テトラデセン―４―オリドの製造方法 |
| TWI347946B (en) * | 2002-10-11 | 2011-09-01 | Otsuka Pharma Co Ltd | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound |
| WO2004035547A1 (ja) | 2002-10-15 | 2004-04-29 | Otsuka Pharmaceutical Co., Ltd. | １位置換―４―ニトロイミダゾール化合物及びその製造法 |
| CN1326840C (zh) * | 2002-10-15 | 2007-07-18 | 大塚制药株式会社 | 1－取代的－4－硝基咪唑化合物及其制备方法 |
| KR101294921B1 (ko) * | 2005-07-28 | 2013-08-08 | 오츠카 세이야쿠 가부시키가이샤 | 2,3-디히드로-6-니트로이미다조〔2,1-ｂ〕옥사졸 유도체 함유 제약 조성물 |
| JP5105818B2 (ja) * | 2005-10-05 | 2012-12-26 | 大塚製薬株式会社 | 医薬組成物 |
| AR070301A1 (es) * | 2007-05-08 | 2010-03-31 | Otsuka Pharma Co Ltd | Compuesto epoxi y metodo para producir el mismo |
| JP2009269859A (ja) * | 2008-05-08 | 2009-11-19 | Otsuka Pharmaceut Co Ltd | Ｎ−含有複素環化合物 |
| US8558005B2 (en) * | 2008-08-21 | 2013-10-15 | Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik | Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof |
-
2011
- 2011-01-26 TW TW100102823A patent/TW201200523A/zh unknown
- 2011-01-28 SG SG2012048450A patent/SG181990A1/en unknown
- 2011-01-28 CA CA2787246A patent/CA2787246A1/en not_active Abandoned
- 2011-01-28 SI SI201130294T patent/SI2528896T1/sl unknown
- 2011-01-28 PL PL11706939T patent/PL2528896T3/pl unknown
- 2011-01-28 JP JP2012534460A patent/JP5818802B2/ja active Active
- 2011-01-28 BR BR112012018069A patent/BR112012018069A2/pt not_active IP Right Cessation
- 2011-01-28 EA EA201290681A patent/EA201290681A1/ru unknown
- 2011-01-28 MX MX2012008501A patent/MX2012008501A/es active IP Right Grant
- 2011-01-28 PT PT117069393T patent/PT2528896E/pt unknown
- 2011-01-28 DK DK11706939.3T patent/DK2528896T3/da active
- 2011-01-28 KR KR1020127021820A patent/KR101839160B1/ko active IP Right Grant
- 2011-01-28 WO PCT/JP2011/052307 patent/WO2011093529A1/en active Application Filing
- 2011-01-28 EP EP11706939.3A patent/EP2528896B1/en active Active
- 2011-01-28 AR ARP110100285A patent/AR080287A1/es unknown
- 2011-01-28 ES ES11706939.3T patent/ES2509946T3/es active Active
- 2011-01-28 NZ NZ601239A patent/NZ601239A/en not_active IP Right Cessation
- 2011-01-28 UA UAA201210058A patent/UA108092C2/ru unknown
- 2011-01-28 CN CN201180006814.0A patent/CN102725269B/zh active Active
- 2011-01-28 MY MYPI2012003014A patent/MY156360A/en unknown
- 2011-01-28 US US13/574,546 patent/US8598358B2/en active Active
- 2011-01-28 AU AU2011211311A patent/AU2011211311A1/en not_active Abandoned
-
2012
- 2012-06-27 ZA ZA2012/04802A patent/ZA201204802B/en unknown
- 2012-07-04 IL IL220754A patent/IL220754A/en not_active IP Right Cessation
- 2012-07-18 EG EG2012071281A patent/EG26595A/en active
-
2013
- 2013-01-24 HK HK13101058.2A patent/HK1174031A1/xx not_active IP Right Cessation
-
2014
- 2014-10-22 CY CY20141100864T patent/CY1115654T1/el unknown
- 2014-11-07 HR HRP20141087AT patent/HRP20141087T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2528896B1 (en) | 2014-08-27 |
| PL2528896T3 (pl) | 2015-01-30 |
| KR101839160B1 (ko) | 2018-03-15 |
| HK1174031A1 (en) | 2013-05-31 |
| TW201200523A (en) | 2012-01-01 |
| WO2011093529A1 (en) | 2011-08-04 |
| US20120302757A1 (en) | 2012-11-29 |
| CY1115654T1 (el) | 2017-01-25 |
| JP2013518033A (ja) | 2013-05-20 |
| DK2528896T3 (da) | 2014-11-10 |
| BR112012018069A2 (pt) | 2016-02-23 |
| EG26595A (en) | 2014-03-20 |
| NZ601239A (en) | 2014-10-31 |
| KR20120130326A (ko) | 2012-11-30 |
| CN102725269A (zh) | 2012-10-10 |
| AU2011211311A1 (en) | 2012-07-26 |
| EA201290681A1 (ru) | 2013-02-28 |
| CA2787246A1 (en) | 2011-08-04 |
| EP2528896A1 (en) | 2012-12-05 |
| SG181990A1 (en) | 2012-08-30 |
| US8598358B2 (en) | 2013-12-03 |
| UA108092C2 (ru) | 2015-03-25 |
| MY156360A (en) | 2016-02-15 |
| ES2509946T3 (es) | 2014-10-20 |
| CN102725269B (zh) | 2015-03-25 |
| MX2012008501A (es) | 2012-08-17 |
| ZA201204802B (en) | 2013-09-25 |
| JP5818802B2 (ja) | 2015-11-18 |
| IL220754A (en) | 2015-10-29 |
| HRP20141087T1 (hr) | 2015-01-16 |
| PT2528896E (pt) | 2014-10-09 |
| SI2528896T1 (sl) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20180094A (es) | Proceso para la producción de cannabidol y delta-9-tetrahidrocannabinol | |
| ES2590504T3 (es) | N-ciclilamidas como nematicidas | |
| ES2722409T3 (es) | Moduladores de ROR gamma (RORy) | |
| ES2613538T3 (es) | Derivados de arilamida como bloqueadores de TTX-S | |
| CL2017002350A1 (es) | Silanos y composiciones curables que contienen dichos silanos como reticulantes | |
| MX2013000432A (es) | Sistema acelerador de reticulador para poliacrilatos. | |
| BR112014019909A8 (pt) | Processo para produção de compostos úteis como antagonistas do receptor de orexina-2 | |
| BR112014005844A2 (pt) | composto orgânico, dispositivo de emisão de luz orgânico, e aparelhos de exibição | |
| AR083729A1 (es) | Fluido para servicio a pozos | |
| MY181228A (en) | Triazine, piperidine and pyrrolidine based hindered amine light stabilizers | |
| MX2019004569A (es) | Metodo para producir 3-alquilsulfanil-2-cloro-n-(1-alquil-1h-tetra zol-5-il)-4-trifluorometilbenzamidas. | |
| BR112016008354A2 (pt) | processo de preparação de alquilaluminoxanos por meio da reação de alquilalumínio com um álcool alílico substituído da fórmula, produto que pode ser obtido por meio do processo, e, uso do produto | |
| MX2014006244A (es) | Metodo para tratar infeccion de virus de hepatitis c usando composiciones que contienen quercetina. | |
| TW201129535A (en) | Alcoholic hydroxyl-containing compounds and making method | |
| AU2010305910A8 (en) | Mixtures for producing photoactive layers for organic solar cells and organic photodetectors | |
| AR080287A1 (es) | Intermediario sintetico de un compuesto de oxazol y metodo para producir el mismo | |
| WO2018088665A3 (ko) | 유기 광전자 소자용 화합물, 유기 광전자 소자 및 표시 장치 | |
| HK1160862A1 (en) | Luminescent material prepared from dianthracene compounds substituted by aromatic rings | |
| BR112015029653A2 (pt) | resina de polidissilazano e métodos de formação de uma resina de polidissilazano e de preparo de uma fibra de carboneto de silício | |
| MX369470B (es) | Medios y método para el tratamiento de tumores sólidos. | |
| PE20141168A1 (es) | Derivados de pirazolidin-3-ona | |
| MX2010005015A (es) | Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero. | |
| PH12014502562A1 (en) | Solvent or solvent composition for organic transistor production | |
| CO6260137A2 (es) | Compuesto de epoxi y metodo para fabricar el mismo | |
| AR073773A1 (es) | Metodo para producir decitabina protegida beta-enriquecida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |